Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Clinical trials sponsored by Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., explained in plain language.
-
New drug aims to get sepsis patients off ventilators faster
Disease control Recruiting nowThis study tests an experimental drug called YD0743 in adults with sepsis who develop severe lung failure (ARDS) and need a breathing machine. The main goal is to see if the drug helps patients spend fewer days on the ventilator compared to a placebo. About 309 ICU patients will …
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New pill aims to ease Post-Surgery pain without opioids
Symptom relief Recruiting nowThis study tests an experimental tablet called HL-1186 for pain after abdominal surgery. About 40 adults will receive either the drug or a placebo to see if it reduces pain and is safe. The goal is to find a better way to manage post-surgery pain.
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New pain pill could ease suffering after surgery
Symptom relief Recruiting nowThis study tests an experimental tablet called HL-1186 for people with moderate to severe pain after surgery. About 72 adults having certain surgeries (orthopedic, abdominal, or chest) will receive either the drug or a placebo. The main goal is to see how well it reduces pain ove…
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New pill aims to ease stuffy noses and facial pain
Symptom relief Recruiting nowThis study tests a new tablet called HTMC0658 in 30 adults with chronic sinusitis (no nasal polyps). The goal is to see if it safely reduces symptoms like congestion, facial pain, and discharge over 12 weeks. Participants will have CT scans and symptom checkups to measure improve…
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 19:21 UTC